|
Arlene Morris brings significant expertise in the establishment of strategic partnerships marketing and operations to MediciNova. She was appointed President and CEO of Affymax Inc. in June 2003. She has over 25 years of management experience from Johnson & Johnson Scios Inc. Coulter Pharmaceutical Inc. and Clearview Projects. While at Coulter she completed numerous transactions including the $1.0 billion merger between Coulter and Corixa and a contractual joint venture with GlaxoSmithKline for Bexxar® valued in excess of $200 million. Previously Ms. Morris was the Vice President of Business Development at Scios Inc. where she completed several high profile transactions including one of the first biotech profit-sharing deals for a late-stage product. From 1977 through 1993 Ms. Morris held various management and executive positions at Johnson & Johnson in sales marketing new product development and business development holding the position of Vice President of Business Development for McNeil Pharmaceutical from 1988 to 1993. She received her B.A. degree in Biology and Chemistry from Carlow College and studied marketing at Western New England College. Arlene is also on the Board of BIO the Biotechnology Industry Organization. | 